SCHEMBL7656135

SCHEMBL7656135

CNCCN1CCN(Cc2cccc3ccccc23)C1=C(C#N)C#N

nearest known ligand 0.67

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.67
HDAC1 Q13547 1/20 0.39
OPRL1 P41146 1/20 0.39
ACHE P22303 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
ATM Q13315 1/20 0.37
TMEM97 Q5BJF2 2/20 0.36
SIGMAR1 Q99720 2/20 0.36
DPP4 P27487 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
FAAH O00519 1/20 0.36
GFER P55789 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654001 0.89 HRH3 (0.64) HRH3HDAC1OPRL1ACHEL3MBTL1
SCHEMBL7665076 0.85 HRH3 (0.71) HRH3HDAC1OPRL1ACHEDPP4
SCHEMBL7657076 0.84 HRH3 (0.76) HRH3HDAC1OPRL1ACHETMEM97
SCHEMBL7655208 0.83 HRH3 (0.74) HRH3HDAC1OPRL1ACHETSHR
SCHEMBL6734004 0.82 HRH3 (0.67) HRH3HDAC1OPRL1DPP4FAAH
SCHEMBL7658318 0.75 HRH3 (0.65) HRH3L3MBTL1DPP4
SCHEMBL7665250 0.75 HRH3 (0.71) HRH3OPRL1ACHE
SCHEMBL7652819 0.75 HRH3 (0.77) HRH3HDAC1OPRL1ACHESIGMAR1
SCHEMBL7666593 0.74 HRH3 (0.71) HRH3OPRL1ACHELMNATP53
SCHEMBL7655725 0.74 HRH3 (0.66) HRH3ACHESIGMAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002085861-A1 IMIDAZOLIDINE COMPOUNDS AND THEIR USE AS CXCR3 ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-10-31 WO disclosed
US-6469002-B1 COMPOUNDS WHICH MODULATE CHEMOKINE RECEPTOR ACTIVITY AND ARE USEFUL IN TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. 2002-10-22 US disclosed